Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Dimethyl Fumarate (Tecfidera): A New Oral Agent for Multiple Sclerosis.
Secondary hemophagocytic lymphohistiocytosis possibly induced by interferon beta-1a therapy.
Demyelinating encephalopathy in adult onset Still's disease: Case report and review of the literatures.
Consequences of perinatal bisphenol A exposure in a mouse model of multiple sclerosis.
Multiple sclerosis in the mount etna region: possible role of volcanogenic trace elements.
Investigation of outer cortical magnetisation transfer ratio abnormalities in multiple sclerosis clinical subgroups.
Wheelchair design for people with neuromuscular disability.
RA: from risk factors and pathogenesis to prevention: Towards prevention of autoantibody-positive rheumatoid arthritis: from lifestyle modification to preventive treatment.
Distal acquired demyelinating symmetric neuropathy associated with colorectal adenocarcinoma: Should it be termed paraneoplastic?
Dynamic Assessment of Social Cognition in Individuals with Multiple Sclerosis: A Pilot Study.
Modulation of Hyperosmotic and Immune-Induced Disruption of the Blood-Brain Barrier by the Nitric Oxide System.
Grasping multiple sclerosis: do quantitative motor assessments provide a link between structure and function?
Cerebral vein changes in relapsing-remitting multiple sclerosis demonstrated by three-dimensional enhanced T (2) (*) -weighted angiography at 3.0 T.
Natalizumab treatment for multiple sclerosis.
Production and use of lentivirus to selectively transduce primary oligodendrocyte precursor cells for in vitro myelination assays.
Registers of multiple sclerosis in Denmark.
Prevalence and natural history of pain in adults with multiple sclerosis: Systematic review and meta-analysis.
New markers of early cardiovascular risk in multiple sclerosis patients: Oxidized-LDL correlates with clinical staging.
A confusing case of multiple sclerosis and central nervous system graft versus host disease.
Systematic review and meta-analysis of interventions for depression and anxiety in persons with multiple sclerosis.
Comorbidities at multiple sclerosis diagnosis.
Preference-based Health status in a German outpatient cohort with multiple sclerosis.
Transplanting of Mesenchymal Stem Cells May Affect Proliferation and Function of CD4+T Cells in Experimental Autoimmune Encephalomyelitis.
Brain atrophy as a non-response predictor to interferon-beta in relapsing-remitting multiple sclerosis.
Comparative Effectiveness Using A Matching-Adjusted Indirect Comparison Between Delayed-Release Dimethyl Fumarate and Fingolimod for The Treatment of Relapsing-Remitting Multiple Sclerosis.
Pages
« first
‹ previous
…
469
470
471
472
473
474
475
476
477
…
next ›
last »